Mirae Asset Global Investments
RPRX icon

Mirae Asset Global Investments’s Royalty Pharma RPRX Stock Holding History

Mirae Asset Global Investments’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.44M Buy
150,556
+4,532
+3% +$236K 0.01% 482
2026
Q1 		$7M Buy
146,024
+1,584
+1% +$69.4K ﹤0.01% 460
2025
Q4 		$5.58M Buy
144,440
+4,309
+3% +$164K 0.02% 523
2025
Q3 		$4.94M Buy
140,131
+31,045
+28% +$1.12M 0.02% 526
2025
Q2 		$3.93M Sell
109,086
-4,632
-4% -$153K 0.01% 523
2025
Q1 		$3.57M Buy
113,718
+38,650
+51% +$1.23M 0.01% 529
2024
Q4 		$1.9M Sell
75,068
-966
-1% -$25.6K 0.01% 680
2024
Q3 		$2.14M Sell
76,034
-12,842
-14% -$356K 0.01% 614
2024
Q2 		$2.37M Buy
88,876
+30,242
+52% +$838K 0.01% 538
2024
Q1 		$1.79M Sell
58,634
-30,264
-34% -$892K ﹤0.01% 1256
2023
Q4 		$2.5M Buy
88,898
+8,908
+11% +$245K 0.01% 1159
2023
Q3 		$2.17M Buy
79,990
+40,582
+103% +$1.21M ﹤0.01% 1147
2023
Q2 		$1.21M Buy
39,408
+20,340
+107% +$689K ﹤0.01% 1455
2023
Q1 		$687K Buy
19,068
+857
+5% +$31.8K ﹤0.01% 1757
2022
Q4 		$720K Sell
18,211
-7,702
-30% -$321K ﹤0.01% 1688
2022
Q3 		$1.04M Buy
+25,913
New +$1.11M ﹤0.01% 1458
2022
Q2 		– Sell
-17,008
Closed -$662K – 2438
2022
Q1 		$662K Buy
17,008
+695
+4% +$27.3K ﹤0.01% 1406
2021
Q4 		$650K Buy
16,313
+1,676
+11% +$65.1K ﹤0.01% 1401
2021
Q3 		$529K Buy
+14,637
New +$569K ﹤0.01% 1474
2021
Q2 		– Sell
-22,481
Closed -$981K – 1730
2021
Q1 		$981K Sell
22,481
-1,998
-8% -$94.7K ﹤0.01% 1137
2020
Q4 		$1.23M Buy
+24,479
New +$1.04M ﹤0.01% 1084

Other funds holding RPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Mitsubishi UFJ Trust & Banking
Mitsubishi UFJ Trust & Banking Tokyo, Japan $45.7B AUM 34.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Mirae Asset Global Investments's RPRX Position: Q2 2026 in Review

Mirae Asset Global Investments increased its Royalty Pharma (RPRX) stake by 3.1% in Q2 2026, buying an estimated $236K and bringing the position to 150,556 shares worth $8.44M. The position accounts for 0.01% of the portfolio, ranked #482.

Mirae Asset Global Investments first reported a position in RPRX in Q4 2020 and has held it in 21 quarters since. 296 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Mirae Asset Global Investments held 150,556 shares of Royalty Pharma worth $8.44M as of Q2 2026.
  • Mirae Asset Global Investments bought 4,532 Royalty Pharma shares in Q2 2026, an estimated $236K.
  • Royalty Pharma made up 0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #482 holding.
  • Mirae Asset Global Investments first reported a position in Royalty Pharma in Q4 2020 and has held it in 21 quarters since.
  • 296 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.